212 related articles for article (PubMed ID: 20626178)
1. Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies.
Hoffner L; Parks WT; Swerdlow SH; Carson JC; Surti U
J Reprod Med; 2010; 55(5-6):219-28. PubMed ID: 20626178
[TBL] [Abstract][Full Text] [Related]
2. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT
Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919
[TBL] [Abstract][Full Text] [Related]
4. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
5. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.
Merchant SH; Amin MB; Viswanatha DS; Malhotra RK; Moehlenkamp C; Joste NE
Hum Pathol; 2005 Feb; 36(2):180-6. PubMed ID: 15754295
[TBL] [Abstract][Full Text] [Related]
6. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
7. P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions.
Hoffner L; Dunn J; Esposito N; Macpherson T; Surti U
Hum Pathol; 2008 Jan; 39(1):63-72. PubMed ID: 17904617
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM
Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308
[TBL] [Abstract][Full Text] [Related]
10. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.
Xing D; Adams E; Huang J; Ronnett BM
Mod Pathol; 2021 May; 34(5):961-982. PubMed ID: 33024305
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of p57
Madi JM; Braga AR; Paganella MP; Litvin IE; Da Ros Wendland EM
Syst Rev; 2016 Oct; 5(1):169. PubMed ID: 27716354
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Androgenetic Complete Hydatidiform Moles with p57
Li MW; Li F; Cheng J; Wang F; Zhou P
Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065
[TBL] [Abstract][Full Text] [Related]
13. Determination of morphologic and immunohistochemical stain (p57
Oranratanaphan S; Khongthip Y; Areeruk W; Triratanachat S; Tantbirojn P; Phupong V; Vongpaisarnsin K; Lertkhachonsuk R
Taiwan J Obstet Gynecol; 2020 Jul; 59(4):570-574. PubMed ID: 32653131
[TBL] [Abstract][Full Text] [Related]
14. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.
Xing D; Miller K; Beierl K; Ronnett BM
Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808
[TBL] [Abstract][Full Text] [Related]
15. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification.
Genest DR; Dorfman DM; Castrillon DH
J Reprod Med; 2002 May; 47(5):342-6. PubMed ID: 12063872
[TBL] [Abstract][Full Text] [Related]
16. Androgenetic/biparental mosaicism in a diploid mole-like conceptus: report of a case with triple paternal contribution.
Donzel M; Gaillot-Durand L; Joubert M; Aziza J; Beneteau C; Mauduit C; Ploteau S; Hajri T; Bolze PA; Massardier J; Devouassoux-Shisheboran M; Sunde L; Allias F
Virchows Arch; 2023 Nov; 483(5):709-715. PubMed ID: 37695410
[TBL] [Abstract][Full Text] [Related]
17. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
Yang SM; You JF; Zhang XW; Zheng J; Liao SL
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184
[TBL] [Abstract][Full Text] [Related]
18. Utility of p57 protein(KIP2) in molar disease to determine its androgenetic origin.
García-Barriola V; de Gómez MN; Dickson-González S; Figueira L; Cortés-Charry R
J Reprod Med; 2008 Jul; 53(7):476-80. PubMed ID: 18720921
[TBL] [Abstract][Full Text] [Related]
19. Recurrent pregnancy loss in a woman with NLRP7 mutation: not all molar pregnancies can be easily classified as either "partial" or "complete" hydatidiform moles.
Brown L; Mount S; Reddy R; Slim R; Wong C; Jobanputra V; Clifford P; Merrill L; Brown S
Int J Gynecol Pathol; 2013 Jul; 32(4):399-405. PubMed ID: 23722513
[TBL] [Abstract][Full Text] [Related]
20. Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2.
Kihara M; Matsui H; Seki K; Nagai Y; Wake N; Sekiya S
J Reprod Med; 2005 May; 50(5):307-12. PubMed ID: 15971478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
